(Q64722999)

English

Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Randomised, Double-blind, in Parallel Groups Placebo-controlled, Mono-centre, Phase I Study to Assess After Allergen Challenge in an Allergen Exposition Chamber the Effect and Its Time Course of Sublingual Immunotherapy (SLIT) Administered as 300IR Allergen-based Tablets Once Daily to Adults Suffering From Grass Pollen Rhinoconjunctivitis (English)

0 references

0 references

0 references

September 2007

0 references

end time

March 2008